Current HIV treatment strategies. See p. 19. Report from the 3rd Conference on Retroviruses and Opportunistic Infections. See p. 26. See p. 21-22.
Optimism rises on combination therapy and protease inhibitor data.
See p. 20. Ganciclovir is an effective CMV prophylaxis drug. Chiron's eye implant device is approved for CMV retinitis. Finding a place for cidofovir.